Release Date: December 10, 2022
Expiration Date: February 1, 2023
Activity Overview
This educational activity is an archive of the live virtual presentation held on December 9, 2022.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This activity is intended for medical oncologists, hematologist/oncologists, hematologists, primary care physicians, hematopathologists, and other healthcare professionals interested in understanding the current treatment guidelines and diagnostic strategies for patients who present with hematologic symptoms of unknown origin.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Determine key processes and criteria for differential diagnosis of rare hematologic disorders
- Explain the pathophysiology of rare blood disorders and its relationship to diagnosis confirmation, and treatment decisions
- Integrate emerging data and updated guidelines into personalized treatment plans for patients with rare hematologic disorders
- Apply strategies to timely monitor and mitigate disease- and treatment-related adverse events in patients with rare blood disorders
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
